Clostridium Difficile Infection Complicated By Toxic Megacolon In Immunocompetent Patient

Author:

Draganescu Miruna1,Baroiu Liliana1,Iancu Alina1,Arbune Manuela1,Dumitru Irina Magdalena2,Rugina S.34

Affiliation:

1. Medicine and Pharmacy Research Center, “Dunărea de Jos” University of Galati, Faculty of Medicine, Romania

2. University “Ovidius” of Constanta, Faculty of Medicine, Romania

3. University “Ovidius” of Constanta, Faculty of Medicine Romania

4. Academy of Romanian Scientists, Romania

Abstract

Abstract Toxic megacolon can be a form of severe clinical course of the infection with Clostridium difficile (ICD), life-threatening, requiring a particular course of treatment. Infection with Clostridium difficile in the Galati Infectious Disease Hospital presents rising number of cases, namely 172 cases in 2014, 271 cases in 2015 and 301 cases in 2016 with clinical evolutions with different severity degrees, including toxic megacolon and death. Among 744 patients with ICD in our clinic, since 1st January 2014 to 31 December 2016. The frequency of toxic megacolon (TM) was 0,537%, so: 3 toxic megacolon cases with favorable evolution with treatment with vancomycin and metronidazole and just one case whose evolution was aggravated under this therapy and evolved favorably under treatment with tigecycline. The work presents this last case of ICD occurred in a 69 years old, immunocompetent man with unknown concomitant chronic diseases which undergoes surgery for bilateral inguinal hernia and receives antibiotherapy with cephalosporin IIIrd generation during surgery and after 7 days develops medium degree ICD with score Atlas 3 and receives therapy with oral vancomycin. He presents clinical aggravation during this therapy with the occurrence of colon dilatation, ascites and right pleurisy at ultrasound and therapy associated with metronidazole is decided. Clinical aggravation continues in this combined therapy with defining the clinical, colonoscopy and tomography criteria for TM and is decided surgical monitoring and replacing antibiotherapy with tigecycline. Evolution is favorable with tigecycline without surgical intervention.

Publisher

Walter de Gruyter GmbH

Subject

General Biochemistry, Genetics and Molecular Biology

Reference31 articles.

1. 1. Cohen, S., Gerding, D., Johnson, S, Kelly, C., Loo, V., McDonald, C., Pepin, J. & Wilcox, M. (2010). Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA), Infection Control & Hospital Epidemiology, Vol. 31, Issue 5, 431-455, DOI: http://dx.doi.org/10.1086/651706.

2. 2. McDonald, L.C., Owings, M. & Jernigan, D.B. (2006). Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003, Emerging Infectious Diseases Journal, Vol. 12, 409-415.

3. 3. Redelings, M.D., Sorvillo, F. & Mascola, L. (2007). Increase in Clostridium difficile-related mortality rates, United States, 1999-2004, Emerging Infectious Diseases Journal, Vol. 13, 1417-1419.

4. 4. Burckhardt, F., Friedrich, A., Beier, D. & Eckmanns, T. (2008). Clostridium difficile surveillance trends, Saxony, Germany, Emerging Infectious Diseases Journal, Vol. 14, pp. 691-692.

5. 5. Gravel, D., Miller, M., Simor, A., Taylor, G., Gardam, M., McGeer, A., Hutchinson, J., Moore, D., Kelly, S., Boyd, D. & Mulvey, M. (2009). Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study. Clin Infect Dis. 48(5), 568-576. doi: 10.1086/596703

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. The role of gut fungi in Clostridioides difficile infection;Biomedical Journal;2023-12

2. Metronidazole/vancomycin;Reactions Weekly;2017-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3